Asia
Shanghai Serum Bio-Technology Gets China Approval for Anti-Bee Venom Serum Trial
Shanghai Serum Bio-Technology (SHA:688163) obtained China's regulatory approval to start clinical trials for its anti-bee venom serum.The serum aims to treat patients with severe bee sting poisoning, according to a Friday filing with the Shanghai bourse.Shares of the antiserum and antitoxin products manufacturer closed 3% higher Friday.
SHA:688163